Near-patient Value Prominex focuses on rapid, low-cost molecular diagnostics suitable for near-patient settings, suggesting sales opportunities with clinics, dialysis centers, point-of-care labs, and urgent care facilities seeking fast PCR-level performance.

Speed and Throughput The Prominex System delivers results in about 5 minutes using dCliP chemistry, enabling conversations with high-volume healthcare providers and hospital networks that prioritize quick turnaround times for actionable results.

Accessible Testing Low-cost, multiplexed molecular assays position Prominex for markets with limited lab infrastructure, providing sales angles to underserved regions, community health programs, and international distributors.

Growth Capital With revenue in the low to mid six figures and a $4M funding base, there is an opportunity to partner on expansion projects, pilot programs, and co-development deals with larger diagnostic distributors.

Strategic Fit Complementary alignment with large testing networks and material technology partners can be explored to scale adoption, leveraging similarities to established players in the industry while offering differentiation through speed and access.